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factors such as growth hormone, insulin, PTH and IGF1. The
primary culture may be split twice without loosing its phenotype,
thus enabling a remarkable cells expansion.
We have shown that maurine and porcine- derived cells injected
into rats’ afflicted (AIA) joints replenish the articular lesion with
typical hyaline cartilage, and with no signs of WBC infiltration.
Since, prior to differentiation, these cells undergo an intensive
proliferation phase, they can also be easily transfected.
We have also shown that osteoprotegerin (OPG)-firstly known for
its activity as RANK ligand decoy receptor, has direct ameliorative
effects on cartilage development. OPG increased proliferation
and differentiation rate of primary chondrocyte culture under
control and catabolic cytokines (IL1 and TNFα)- treated cultures.
Moreover, we have shown that OPG transfected chondrocytes
preserve their typical morphological and functional features.
Conclusions: Therefore, we propose that these primary
spontaneously- differentiating chondrocytes appears to be pro-
genitor cells capable of replenishment of articular lesions and
could also serve as a vehicle for local application of cytokines
like OPG.
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Purpose: The aim of this study was to construct the tissue-
engineering cartilage (TEC) using a bone matrix gelatin (BMG)
scaffold for use in an in vitro cartilage repair model in mature
rabbits.
Methods: Chondrocytes were isolated from articular cartilage
or induced from mesenchymal stem cells (MSCs) harvested
from mature New Zealand white rabbits. The cancellous and
cortical bone BMG scaffold was prepared and chondrocytes
were seeded onto the BMG. The chondrocytes were seeded onto
the cancellous BMG and cultured in vitro for 12 days and then
the complex was implanted into osteochondral cartilage defects
made in the rabbit knee joint. The rabbits were sacrificed at
different time intervals for evaluation of joint function, morphology,
and histological analyses. The TEC was also characterized with
immunohistochemistal and biochemical assays.
Results: After 6 days implantation, 1∼3 cell layers of chondro-
cytes were found to be proliferating on the surface of the BMG
scaffold. After 12 days implantation, the number of chondrocytes
had increase forming a cartilaginous-like tissue of 10∼12 cell
layers with a Safranin-O positive extracellular matrix. After 18
days implantation the neo-cartilage was thicker and immunopos-
itive for type II collagen. After 24∼42 days of implantation, more
cells accumulated forming a repaired cartilage of 25∼30 cell lay-
ers which was Safranin-O and collagen II positive similar to that
seen in articular cartilage. The chondrocytes of neo-cartilaginous
tissue were found to be on the BMG surface and to be in and
around pores of cancellous bone BMG. All rabbits could move
normally within 10 days after the complex was implanted. The
BMG scaffold was resorbed within 8 weeks of implantation. After
24 weeks implantation the cartilage defects were fully repaired
with integrated articular cartilage and subchondral bone. Similar
results were obtained using chondrocytes from MSC expanded
cultures.
Conclusions: The construction of tissue-engineering cartilage
using resorbable BMG scaffolds was successful in producing
tissue engineered cartilage for in vivo transplantation and suc-
cessful repair of osteochondral defects in a rabbit injury model.
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Purpose: In recent years, several clinical studies have suggested
that the local administration of platelet (PLT) derivatives, such as
PLT gel and PLT-rich plasma (PRP), have the potential for a sub-
stantial therapeutic role in tissue regeneration. However, these
studies are often based on anecdotal cases and their results are
sometimes conflicting, highlighting the need for an in-depth anal-
ysis of the complex molecular mechanisms that take part in the
regenerative cellular processes. In this direction, an extensive in
vitro experimentation has been developed, focused on the bio-
logical effects that high concentrated PLT derivatives can exert
on cultured fibroblasts, osteoblasts and chondrocytes. Platelets
are known to actively participate in healing processes by deliv-
ering a broad spectrum of growth factors (GFs) and other active
molecules to the injured site. GFs secreted by platelets syner-
gically act on local cells inducing specific responses: TGF β-I,
PDGF, and IGF-I, promote proliferation, cell migration and syn-
thesis of extracellular matrix, while other released substances,
like VEGF, HGF and bFGF, promote angiogenesis and vasculari-
sation. Articular cartilage is an avascular tissue that has a limited
capacity for self repair. Recently proposed cell-based cartilage
repair procedures require that autolougous articular chondro-
cytes are isolated from a small biopsy, expanded in vitro, and
then either directly injected into the defect or used to engineer
implantable grafts. Several cultural problems, that have limited
the wide clinical application of these techniques, have been ame-
liorated with the introduction of mixtures of recombinant GFs and
the employment of a variety of biocompatible matrices that sup-
port an appropriate tissue formation in vitro and in vivo. Many
GFs are able to induce chondrocyte proliferation and differen-
tiation, but they are quite expensive and their effects strongly
vary in function of their synergy and combination. These cultural
aspects, have suggested the use of concentrated autologous
or homologogous PLT preparations as rich, safe and economic
sources of GFs to be added to cultural medium. The aim of
our study was to demonstrate the mitogenic and differentiating
properties of PRP releasates (PRPr) on human chondrocytes in
mono and three-dimensional cultures.
Methods: In order to assess if PRPr supplementation could
maintain the chondrocyte phenotype or at least inhibit the cell
de-differentiation, we performed time-dependent biochemical and
Real-time PCR gene expression analyses on several cell cultures
independently grown in culture medium with: FCS, human serum
(HS) and PRP and platelet poor plasma (PPP) releasates added
at the same proteic concentration (2 mg/ml).
Results: In comparison with equal amounts of FCS, HS and PPP,
the PRPr was able to enhance the chondrocyte proliferation (up
to 195%) and to increase the expression of Sox9 (about 3 folds),
and Collagen II (2.5 folds) in the first 2 days of culture. Moreover,
an active secretion of proteoglicans was observed, after 20 days
of treatment, only for PRPr-treated cells.
Conclusions: The results of our study support the use of PLT
derivatives for the expansion in culture of fully differentiated
chondrocytes.
